310 related articles for article (PubMed ID: 20964565)
1. Comparison of the efficacy of 5% topical spironolactone gel and placebo in the treatment of mild and moderate acne vulgaris: a randomized controlled trial.
Afzali BM; Yaghoobi E; Yaghoobi R; Bagherani N; Dabbagh MA
J Dermatolog Treat; 2012 Feb; 23(1):21-5. PubMed ID: 20964565
[TBL] [Abstract][Full Text] [Related]
2. Spironolactone loaded nanostructured lipid carrier gel for effective treatment of mild and moderate acne vulgaris: A randomized, double-blind, prospective trial.
Kelidari HR; Saeedi M; Hajheydari Z; Akbari J; Morteza-Semnani K; Akhtari J; Valizadeh H; Asare-Addo K; Nokhodchi A
Colloids Surf B Biointerfaces; 2016 Oct; 146():47-53. PubMed ID: 27248464
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of topical cyproterone acetate alcohol lotion versus placebo in the treatment of the mild to moderate acne vulgaris: a double blind study.
Iraji F; Momeni A; Naji SM; Siadat AH
Dermatol Online J; 2006 Mar; 12(3):26. PubMed ID: 16638440
[TBL] [Abstract][Full Text] [Related]
4. FASCE, the benefit of spironolactone for treating acne in women: study protocol for a randomized double-blind trial.
Poinas A; Lemoigne M; Le Naour S; Nguyen JM; Schirr-Bonnans S; Riche VP; Vrignaud F; Machet L; Claudel JP; Leccia MT; Hainaut E; Beneton N; Dert C; Boisrobert A; Flet L; Chiffoleau A; Corvec S; Khammari A; Dréno B
Trials; 2020 Jun; 21(1):571. PubMed ID: 32586344
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of 5% topical tea tree oil gel in mild to moderate acne vulgaris: a randomized, double-blind placebo-controlled study.
Enshaieh S; Jooya A; Siadat AH; Iraji F
Indian J Dermatol Venereol Leprol; 2007; 73(1):22-5. PubMed ID: 17314442
[TBL] [Abstract][Full Text] [Related]
6. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
[TBL] [Abstract][Full Text] [Related]
7. Clindamycin lotion alone versus combination lotion of clindamycin phosphate plus tretinoin versus combination lotion of clindamycin phosphate plus salicylic acid in the topical treatment of mild to moderate acne vulgaris: a randomized control trial.
NilFroushzadeh MA; Siadat AH; Baradaran EH; Moradi S
Indian J Dermatol Venereol Leprol; 2009; 75(3):279-82. PubMed ID: 19439881
[TBL] [Abstract][Full Text] [Related]
8. Allergic contact dermatitis from spironolactone.
Corazza M; Strumìa R; Lombardi AR; Virgili A
Contact Dermatitis; 1996 Dec; 35(6):365-6. PubMed ID: 9118635
[No Abstract] [Full Text] [Related]
9. The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial.
Babaeinejad SH; Fouladi RF
J Drugs Dermatol; 2013 Jul; 12(7):790-4. PubMed ID: 23884492
[TBL] [Abstract][Full Text] [Related]
10. Spironolactone and topical retinoids in adult female cyclical acne.
Lessner E; Fisher S; Kobraei K; Osleber M; Lessner R; Elliott L; Wesson S
J Drugs Dermatol; 2014 Feb; 13(2):126-9. PubMed ID: 24509960
[TBL] [Abstract][Full Text] [Related]
11. Spironolactone for the Treatment of Acne: A 4-Year Retrospective Study.
Grandhi R; Alikhan A
Dermatology; 2017; 233(2-3):141-144. PubMed ID: 28472793
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris.
Iraji F; Sadeghinia A; Shahmoradi Z; Siadat AH; Jooya A
Indian J Dermatol Venereol Leprol; 2007; 73(2):94-6. PubMed ID: 17456913
[TBL] [Abstract][Full Text] [Related]
13. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
[TBL] [Abstract][Full Text] [Related]
14. Topical epidermal growth factor for the improvement of acne lesions: a randomized, double-blinded, placebo-controlled, split-face trial.
Kim HK; Yeo IK; Li K; Kim BJ; Kim MN; Hong CK
Int J Dermatol; 2014 Aug; 53(8):1031-6. PubMed ID: 24962549
[TBL] [Abstract][Full Text] [Related]
15. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
Farquhar C; Lee O; Toomath R; Jepson R
Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
[TBL] [Abstract][Full Text] [Related]
16. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
Marazzi P; Boorman GC; Donald AE; Davies HD
J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
[TBL] [Abstract][Full Text] [Related]
17. Low Usefulness of Potassium Monitoring Among Healthy Young Women Taking Spironolactone for Acne.
Plovanich M; Weng QY; Mostaghimi A
JAMA Dermatol; 2015 Sep; 151(9):941-4. PubMed ID: 25796182
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of amoxicillin, trimethoprim-sulfamethoxazole, and spironolactone for treatment-resistant acne vulgaris.
Turowski CB; James WD
Adv Dermatol; 2007; 23():155-63. PubMed ID: 18159900
[TBL] [Abstract][Full Text] [Related]
19. Topical retinoids in inflammatory acne: a retrospective, investigator-blinded, vehicle-controlled, photographic assessment.
Leyden JJ; Shalita A; Thiboutot D; Washenik K; Webster G
Clin Ther; 2005 Feb; 27(2):216-24. PubMed ID: 15811485
[TBL] [Abstract][Full Text] [Related]
20. Oral Spironolactone for Acne Vulgaris in Adult Females: A Hybrid Systematic Review.
Layton AM; Eady EA; Whitehouse H; Del Rosso JQ; Fedorowicz Z; van Zuuren EJ
Am J Clin Dermatol; 2017 Apr; 18(2):169-191. PubMed ID: 28155090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
